- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
This drug stock has stumbled on a failed clinical trial, but here's why the stock is a bargain right now.
A quick-turning reversal pattern is all that is needed to set things in motion.
Cramer says Bristol-Myers is the value stock to own and Foot Locker is doing as well as he predicted.
Demand is quite healthy and markets are not going into the abyss, Cramer says.